Constance Ames serves as Executive at Axsome Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Constance Ames has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 24, 2015 involved exercising options for 4,358 shares valued at $25.9K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 24, 2015 | AXSM | $25.9K | Conversion | 4,358 | $5.94 | Discretionary |
Constance Ames currently holds 4,358 shares of Axsome Therapeutics, Inc. (AXSM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Constance Ames has been a net neutral trader of AXSM stock. They have purchased $0 and sold $0 worth of shares.
Constance Ames's most recent insider trade was on Nov 24, 2015, when they sold 4,358 shares at $5.94 per share.
Get notified when new Form 4 filings are submitted